Hypoxia enhances ligand-occupied androgen receptor activity

Biochemical and Biophysical Research Communications

Volumn 418, Issue 2, 2012, Pages 319-323

  Park, Choa ^a   Kim, Yiseul ^a   Shim, Myeongkuk ^a   Lee, YoungJoo ^a  

^a Sejong University   (South Korea)

Author keywords

Androgen receptor; Dihydrotestosterone; Hypoxia

Indexed keywords

ANDROGEN RECEPTOR; ANDROSTANOLONE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; VASCULOTROPIN;

ARTICLE; CELL STRAIN LNCAP; HUMAN; HUMAN CELL; HYPOXIA; MALE; PLASMID; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN SECRETION; TRANSCRIPTION INITIATION;

ANDROGENS; CELL HYPOXIA; CELL LINE, TUMOR; DIHYDROTESTOSTERONE; GENES, REPORTER; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LIGANDS; LUCIFERASES; MALE; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION;

EID: 84862817122     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.01.019     Document Type: Article

References (27)

1. Shan L.X., Bardin C.W., Hardy M.P. Immunohistochemical analysis of androgen effects on androgen receptor expression in developing Leydig and Sertoli cells. Endocrinology 1997, 138:1259-1266.
2. Heinlein C.A., Chang C. Androgen receptor in prostate cancer. Endocr. Rev. 2004, 25:276-308.
3. Heemers H.V., Tindall D.J. Androgen receptor (AR) coregulators: a diversity of functions converging on and regulating the AR transcriptional complex. Endocr. Rev. 2007, 28:778-808.
4. Ueda T., Bruchovsky N., Sadar M.D. Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways. J. Biol. Chem. 2002, 277:7076-7085.
5. Zander R., Vaupel P. Proposal for using a standardized terminology on oxygen transport to tissue. Adv. Exp. Med. Biol. 1985, 191:965-970.
6. Liao D., Johnson R.S. Hypoxia: a key regulator of angiogenesis in cancer. Cancer Metastasis Rev. 2007, 26:281-290.
7. Kim M., Park S.Y., Pai H.S., Kim T.H., Billiar T.R., Seol D.W. Hypoxia inhibits tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by blocking bax translocation. Cancer Res. 2004, 64:4078-4081.
8. Wenger R.H., Stiehl D.P., Camenisch G. Integration of oxygen signaling at the consensus Hre. Sci. STKE 2005, 306:re12.
9. 2 tension. Proc. Natl. Acad. Sci. USA 1995, 92:5510-5514.
10. Milosevic M., Chung P., Parker C., Bristow R., Toi A., Panzarella T., Warde P., Catton C., Menard C., Bayley A., Gospodarowicz M., Hill R. Androgen withdrawal in patients reduces prostate cancer hypoxia: implications for disease progression and radiation response. Cancer Res. 2007, 67:6022-6025.
11. Stoner M., Saville B., Wormke M., Dean D., Burghardt R., Safe S. Hypoxia induces proteasome-dependent degradation of estrogen receptor alpha in ZR-75 breast cancer cells. Mol. Endocrinol. 2002, 16:2231-2242.
12. Cho J., Kim D., Lee S., Lee Y. Cobalt chloride-induced estrogen receptor alpha down-regulation involves hypoxia-inducible factor-1alpha in MCF-7 human breast cancer cells. Mol. Endocrinol. 2005, 19:1191-1199.
13. Mak P., Leav I., Pursell B., Bae D., Yang X., Taglienti C.A., Gouvin L.M., Sharma V.M., Mercurio A.M. ERbeta impedes prostate cancer EMT by destabilizing HIF-1alpha and inhibiting VEGF-mediated snail nuclear localization: implications for Gleason grading. Cancer Cell 2010, 17:319-332.
14. Huang Y., Zhao J.J., Lv Y.Y., Ding P.S., Liu R.Y. Hypoxia down-regulates glucocorticoid receptor alpha and attenuates the anti-inflammatory actions of dexamethasone in human alveolar epithelial A549 cells. Life Sci. 2009, 85:107-112.
15. Brahimi-Horn M.C., Pouysségur J. Oxygen, a source of life and stress. FEBS Lett. 2007, 581:3582-3591.
16. Folkman J. Tumor angiogenesis: therapeutic implications. N. Engl. J. Med. 1971, 285:1182-1186.
17. Shabsigh A., Chang D.T., Heitjan D.F., Kiss A., Olsson C.A., Puchner P.J., Buttyan R. Rapid reduction in blood flow to the rat ventral prostate gland after castration: preliminary evidence that androgens influence prostate size by regulating blood flow to the prostate gland and prostatic endothelial cell survival. Prostate 1998, 36:201-206.
18. Jain R.K., Safabakhsh N., Sckell A., Chen Y., Jiang P., Benjamin L., Yuan F., Keshet E. Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: role of vascular endothelial growth factor. Proc. Natl. Acad. Sci. USA 1998, 95:10820-10825.
19. Sieveking D.P., Lim P., Chow R.W., Dunn L.L., Bao S., McGrath K.C., Heather A.K., Handelsman D.J., Celermajer D.S., Ng M.K. A sex-specific role for androgens in angiogenesis. J. Exp. Med. 2010, 207:345-352.
20. Horii K., Suzuki Y., Kondo Y., Akimoto M., Nishimura T., Yamabe Y., Sakaue M., Sano T., Kitagawa T., Himeno S., Imura N., Hara S. Androgen-dependent gene expression of prostate-specific antigen is enhanced synergistically by hypoxia in human prostate cancer cells. Mol. Cancer Res. 2007, 5:383-391.
21. Miyamoto H., Yang Z., Chen Y.T., Ishiguro H., Uemura H., Kubota Y., Nagashima Y., Chang Y.J., Hu Y.C., Tsai M.Y., Yeh S., Messing E.M., Chang C. Promotion of bladder cancer development and progression by androgen receptor signals. J. Natl. Cancer Inst. 2007, 99:558-568.
22. Kim J.H., Kim J.H., Yu Y.S., Shin J.Y., Lee H.Y., Kim K.W. Deguelin inhibits retinal neovascularization by down-regulation of HIF-1alpha in oxygen-induced retinopathy. J. Cell Mol. Med. 2008, 12:2407-2415.
23. Hua K., Din J., Cao Q., Feng W., Zhang Y., Yao L., Huang Y., Zhao Y., Feng Y. Estrogen and progestin regulate HIF-1alpha expression in ovarian cancer cell lines via the activation of Akt signaling transduction pathway. Oncol. Rep. 2009, 21:893-898.
24. Park S.Y., Kim Y.J., Gao A.C., Mohler J.L., Onate S.A., Hidalgo A.A., Ip C., Park E.M., Yoon S.Y., Park Y.M. Hypoxia increases androgen receptor activity in prostate cancer cells. Cancer Res. 2006, 66:5121-5129.
25. Khandrika L., Lieberman R., Koul S., Kumar B., Maroni P., Chandhoke R., Meacham R.B., Koul H.K. Hypoxia-associated p38 mitogen-activated protein kinase-mediated androgen receptor activation and increased HIF-1alpha levels contribute to emergence of an aggressive phenotype in prostate cancer. Oncogene 2009, 28:1248-1260.
26. Mitani T., Yamaji R., Higashimura Y., Harada N., Nakano Y., Inui H. Hypoxia enhances transcriptional activity of androgen receptor through hypoxia-inducible factor-1α in a low androgen environment. J. Steroid Biochem. Mol. Biol. 2011, 123:58-64.
27. Park Y.M., Cho J.Y., Koo Y.D., Lee Y.J. Effects of inhibiting the proteasomal degradation of estrogen receptor alpha on estrogen receptor alpha activation under hypoxic conditions. Biol. Pharm. Bull. 2009, 32:2057-2060.